We're a team of scientists, engineers, and computational chemists building software that transforms how drugs and materials are discovered. Founded in 1990, we started with a simple but ambitious idea: use physics-based simulations to predict molecular behavior with accuracy that could actually guide real-world research. Today, our platform combines molecular simulation with machine learning, helping pharmaceutical companies, biotech firms, and industrial researchers find promising molecules faster and more cost-effectively than traditional trial-and-error methods.
What makes us different is that we're not just building software - we're actively applying these tools ourselves through drug discovery collaborations. We've seen our platform help researchers identify compounds they never would have considered, and we've watched computational predictions translate into real experimental results. Our team spans physics, chemistry, biology, and computer science, all working together to solve problems that sit at the intersection of these fields. We're proud to partner with over 1,600 organizations across 70 countries, and we're constantly pushing the boundaries of what's possible when you bring rigorous physics together with modern AI.
